Phase 3 Study to Test Oral Combination, Tecfidera and Ponesimod, to Treat Relapsing MS
…
How Tecfidera Works to Reduce MS Relapses Finally Discovered, May Lead to Better Treatments
…
Stuart Schlossman
Change in Clinical Test Dose of Potential MS Therapy, Laquinimod, Triggers FDA Response
…
Stuart Schlossman
Geneuro Tries A Different Take On Multiple Sclerosis
…
Stuart Schlossman
MS drug coverage policy changes by United Healthcare
…
Stuart Schlossman
The AAN (American Academy of Neurology) seeks comments from MS Patients and Caregivers
…
Stuart Schlossman
MS Treatment Guideline — MS Patient Comments are being requested
…
Stuart Schlossman
Registry Data: Lemtrada More Effective than Competing MS Tx
…
Stuart Schlossman
Siponimod May Slow Worsening in SPMS
…
Stuart Schlossman
Novartis BAF312 reduced the risk of disability progression in pivotal phase III study in secondary progressive MS patients
…
Stuart Schlossman
